(Q13896859)
Statements
1 reference
Pembrolizumab (English)
17 November 2015
1 reference
pembrolizumab (English)
0 references
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
8 April 2021
1 May 2016
1 reference
Pembrolizumab (English)
17 November 2015
1 reference
1 reference
Pembrolizumab (English)
17 November 2015
Identifiers
1 reference
Pembrolizumab (English)
17 November 2015
1 reference
Pembrolizumab (English)
19 January 2016
1 reference
28 October 2019
PEMBROLIZUMAB (English)
10 May 2021
807-012-2
1 reference
27 December 2018
[Name confidential or not available] (English)
CAS no.: 1374853-91-4 (English)
1 reference
27 December 2018
[Name confidential or not available] (English)
CAS no.: 1374853-91-4 (English)
pembrolizumab
1 reference
1 reference
PEMBROLIZUMAB (English)
19 January 2016
1 reference
PEMBROLIZUMAB (English)
19 January 2016
1 reference
Pembrolizumab (English)
19 January 2016
1 reference
Pembrolizumab
2 references
9 March 2022
Sitelinks
Wikipedia(24 entries)
- arwiki بمبروليزوماب
- dewiki Pembrolizumab
- enwiki Pembrolizumab
- eswiki Pembrolizumab
- fawiki پمبرولیزومب
- fiwiki Pembrolitsumabi
- frwiki Pembrolizumab
- hewiki פמברוליזומאב
- itwiki Pembrolizumab
- jawiki ペムブロリズマブ
- kowiki 키트루다
- mkwiki Пембролизумаб
- nlwiki Pembrolizumab
- nowiki Pembrolizumab
- orwiki ପେମ୍ବ୍ରୋଲିଜୁମାବ
- plwiki Pembrolizumab
- ptwiki Pembrolizumabe
- rowiki Pembrolizumab
- ruwiki Пембролизумаб
- slwiki Pembrolizumab
- trwiki Pembrolizumab
- ukwiki Пембролізумаб
- viwiki Pembrolizumab
- zhwiki 帕博利珠单抗